Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motokuni Aoki

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Molecular and Cellular Cardiology|July 26, 2005
Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytesHironori Tashiro, Motokuni Aoki, Mitsuaki Isobe, et al.
International Journal of Molecular Medicine|November 21, 2008
Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartanYoshikazu Fujiwara, Suguru Shiraya, Takashi Miyake, et al.
Acta Medica Okayama|July 29, 2005
Hepatocyte growth factor gene therapy reduces ventricular arrhythmia in animal models of myocardial ischemiaAkihisa Yumoto, Kengo Fukushima Kusano, Kazufumi Nakamura, et al.
Circulation Research|September 22, 2007
Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit modelTakashi Miyake, Motokuni Aoki, Hisao Masaki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2012
Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial diseaseHirofumi Makino, Motokuni Aoki, Naotaka Hashiya, et al.
The Journal of Gene Medicine|September 29, 2007
Improvement of survival of skin flaps by combined gene transfer of hepatocyte growth factor and prostacyclin synthaseAya Nakagawa, Hirofumi Makino, Motokuni Aoki, et al.
Current Gene Therapy|October 16, 2012
Therapeutic effect of ribbon-type nuclear factor-κB decoy oligonucleotides in a rat model of inflammatory bowel diseaseKazunari Ozaki, Hirofumi Makino, Motokuni Aoki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2004
Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factorHirofumi Makino, Motokuni Aoki, Naotaka Hashiya, et al.
Heart and Vessels|March 20, 2003
Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive ratsKeiko Matsumoto, Ryuichi Morishita, N Tomita, et al.
Biochemical and Biophysical Research Communications|March 12, 2004
No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in miceAtsushi Matsuki, Seiji Yamamoto, Hironori Nakagami, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Molecular and Cellular Cardiology|July 26, 2005
Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytesHironori Tashiro, Motokuni Aoki, Mitsuaki Isobe, et al.
International Journal of Molecular Medicine|November 21, 2008
Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartanYoshikazu Fujiwara, Suguru Shiraya, Takashi Miyake, et al.
Acta Medica Okayama|July 29, 2005
Hepatocyte growth factor gene therapy reduces ventricular arrhythmia in animal models of myocardial ischemiaAkihisa Yumoto, Kengo Fukushima Kusano, Kazufumi Nakamura, et al.
Circulation Research|September 22, 2007
Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit modelTakashi Miyake, Motokuni Aoki, Hisao Masaki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2012
Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial diseaseHirofumi Makino, Motokuni Aoki, Naotaka Hashiya, et al.
The Journal of Gene Medicine|September 29, 2007
Improvement of survival of skin flaps by combined gene transfer of hepatocyte growth factor and prostacyclin synthaseAya Nakagawa, Hirofumi Makino, Motokuni Aoki, et al.
Current Gene Therapy|October 16, 2012
Therapeutic effect of ribbon-type nuclear factor-κB decoy oligonucleotides in a rat model of inflammatory bowel diseaseKazunari Ozaki, Hirofumi Makino, Motokuni Aoki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2004
Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factorHirofumi Makino, Motokuni Aoki, Naotaka Hashiya, et al.
Heart and Vessels|March 20, 2003
Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive ratsKeiko Matsumoto, Ryuichi Morishita, N Tomita, et al.
Biochemical and Biophysical Research Communications|March 12, 2004
No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in miceAtsushi Matsuki, Seiji Yamamoto, Hironori Nakagami, et al.
Pageof 5